Management of Hypertensive Crisis in Acute Epistaxis

Guideline Recommendations

The European Society of Cardiology recommends labetalol as first-line therapy for most hypertensive emergencies, administered as 20 mg IV bolus over 2 minutes, followed by repeat boluses of 40-80 mg every 10 minutes (maximum 300 mg cumulative) or continuous infusion at 5-20 mg/h 1
The European Society of Cardiology confirms labetalol's role in hypertensive crisis management across multiple clinical scenarios 2
The American College of Cardiology/American Heart Association guidelines list labetalol among preferred agents for hypertensive emergencies 3

Initial dosing should start with 20 mg IV bolus over 2 minutes, producing rapid but not abrupt blood pressure reduction (mean decrease of 23/14 mmHg after first dose) 1
If blood pressure remains elevated after 10 minutes, give incremental boluses of 40-80 mg every 10 minutes 1
Target blood pressure reduction of approximately 20-25% from baseline within the first hour 1

Absolute contraindications to labetalol administration include second- or third-degree AV block, systolic heart failure, severe bradycardia (<60 bpm), active asthma or severe bronchospasm 1 3
Monitor blood pressure every 5 minutes during bolus administration 1

Labetalol is preferred over nicardipine in scenarios of active bleeding due to its lack of reflex tachycardia 1
Pure β-blockers without α-blockade, like esmolol, are reserved for specific scenarios and may cause unopposed α-stimulation if catecholamines are elevated 1 3